US Patent Issued to NOVOCURE on Aug. 12 for "Compositions and methods for increasing cancer cell sensitivity to alternating electric fields" (Israeli Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,738, issued on Aug. 12, was assigned to NOVOCURE GMBH (Switzerland).

"Compositions and methods for increasing cancer cell sensitivity to alternating electric fields" was invented by Lilach Avigdor (Haifa, Israel) and Tali Voloshin-Sela (Haifa, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods of increasing sensitivity of a cancer cell to alternating electric fields comprising exposing the cancer cell to an alternating electric field for a period of time, the alternating electric field having a frequency and field strength, and exposing the cancer cell to an IGFR1 inhibitor, JNK inhibitor, RPS6 inhibitor or ERK inhibi...